Video Modules

Share

Program Content

Activities

  • LS-SCLC Management
    Management of Limited-Stage SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 30, 2020

    Expires: November 29, 2021

  • IO Rationale for ES-SCLC
    Rationale for Using Immunotherapy in the Treatment of ES-SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 01, 2020

    Expires: November 30, 2021

  • First-line IO for ES-SCLC
    Overview of Immunotherapy Options for Treatment-Naive ES-SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 01, 2020

    Expires: November 30, 2021

  • Case: Frontline ES-SCLC
    Case Discussion: Newly Diagnosed ES-SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2020

    Expires: December 08, 2021

  • Relapsed ES-SCLC
    Overview of Therapeutic Options for Relapsed ES-SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 01, 2020

    Expires: November 30, 2021

  • Case: Relapsed ES-SCLC
    Case Discussion: Relapsed ES-SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 05, 2021

    Expires: February 04, 2022

  • Case: Managing irAEs
    Case Discussion: Management of Immune-Related AEs
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 05, 2021

    Expires: February 04, 2022

  • Radiation for ES-SCLC
    Role of Radiation Therapy in the Management of ES-SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 02, 2021

    Expires: February 01, 2022

  • Biomarkers for IO in SCLC
    Biomarkers for Immunotherapy in SCLC: Where Are We and Where Are We Going?
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 01, 2021

    Expires: January 31, 2022

  • IO Trials in SCLC
    Key Clinical Trials of Immunotherapy in SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 02, 2021

    Expires: February 01, 2022

Provided by

ProCE Banner

Supporters

AstraZeneca

Merck Sharp & Dohme Corp.